Monitoring Guidelines

Tests and Examinations Recommended for Patients with Alström Syndrome

  1. Vision – ERG yearly in childhood, look for subcapsular cataracts.  Red-orange tinted lenses helpful for photodysphoria.  Anticipate total blindness, so early Braille and mobility training is important.

  2. Hearing – Audiometry, otolaryngological evaluation yearly for all patients.  Myringotomy tubes have been helpful, with careful monitoring and precautions during and after surgery.

  3. Cardiac – ECG for all patients (exercise ECG). Echocardiography for all patients every 6 month or yearly, even if asymptomatic.  T/A –24 hour measurement yearly.  Holter monitoring every two or three years.  Successful heart transplantation has been reported in some patients with Alstrom Syndrome.

  4. Hepatic – ALT / AST, GGT yearly for all patients. Evaluate for steatosis/steatohepatitis. For all patients liver sonography and Doppler once.  If there are high transaminases, Doppler of liver yearly.  If portal hypertension exists, band ligation and beta-blocker-propranolol or nadolol and very close control.

  5. Endocrine - Detailed Endrocrine Guidelines LINK

Consensus Clinical Management Guidelines for Alström Syndrome

  • Hyperlipidemia – Evaluation at least yearly.

  • Diabetes – Evaluation at least yearly. If hyperinsulinemia, fasting blood glucose – every 2-3 months, and diet adjustments. For diabetes mellitus, Acarbose, Metformin. Insulin is sometimes necessary.

  • Obesity – Weight, height, BMI every 3 months. Diet adjustments. Exercise: walking, hiking, biking in tandem, swimming.

  • Thyroid –TSH, fT4, fT3 and sonography of thyroid gland. Replacement with Levothyroxin, if deficiency.

  • Sexual function – Males: anamnesis of erection, libido, secondary sexual characteristics, measurement of genitalia. Sonography of penis and testicles. Examine for gynecomastia. Testosterone replacement for males, if necessary transdermal patch or injection. In females: anamnesis of hyperandrogenism, menstruation, secondary sexual characteristics. Sonography of ovaries and uterus. In blood: Testosterone, FSH, and LH.

  • Pulmonology – X-Ray, Spirography -FVC , FEV1 and FEV25-75% for all patients. If obstructive, determine if spastic components exist and treat accordingly. If there is chronic bronchitis, yearly evaluation of lung function. Assess pulmonary hypertension. Note: patients often have difficulty in completing PFTs, so assessment can be difficult.

  1. Digestive – Anamnesis of reflux-esophagitis. If there is suspicion, barium X-ray and esophagogastroduodenoscopy. If needed, Omeprazole and/or Metoclopramide.

  2. Renal – Urinalysis and serum creatinine, BUN, uric acid, creatinine clearance, electrolytes every 6 months.  Every 1-2 years, renal sonography. If proteinuria exists, urine protein electrophoresis, and ACE inhibitors.

  3. Skin – Acanthosis nigricans, alopecia, body hair, hirsutism.

  4. Bone and muscles – Flat feet, scoliosis, kyphosis, barrel chest.

  5. Neurological – Routine examination – if indicated, EEG.

  6. Immunological – Yearly vaccination against influenza, and routinely against measles, rubella, chicken pox and pertussis. Hepatitis A, if there are no Anti HAV- IgG, and B.

  7. Other   Sleep apnea study, if needed.

REFERENCES:

1. Marshall JD, Maffei P, Beck S, Barrett TG, Paisey R, Naggert JK. Clinical utility gene card for: Alström syndrome – update 2013. Eur J Hum Genet. 2013 Apr 24. doi: 10.1038/ejhg.2013.61. [Epub ahead of print]

2. Marshall JD, Paisey RB, Carey CM, McDermott S. (2010) in: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2003 [updated 2010 Jun 8].

3. Tahani N, Maffei P, Dollfus H, Paisey R, Valverde D, Milan G, Han JC, Favaretto F, Madathil SC, Dawson C, Armstrong MJ, Warfield AT, Düzenli S, Francomano CA, Gunay-Aygun M, Dassie F, Marion V, Valenti M, Leeson-Beevers K, Chivers A, Steeds R, Barrett T, Geberhiwot T. Consensus clinical management guidelines for Alström syndrome. Orphanet J Rare Dis. 2020 Sep 21;15(1):253. doi: 10.1186/s13023-020-01468-8. PMID: 32958032; PMCID: PMC7504843.

Next
Next

Jamie’s Resource List for the Visually Impaired